Drug intended to prevent premature birth should be pulled from market, FDA panel recommends

FDA advisory panel said it remains doubtful that Makena, a drug intended to prevent preterm births works. The panel voted to recommend the FDA withdraw its approval.

Powered by NewsAPI , in News on .

news image
FDA advisory panel said it remains doubtful that Makena, a drug intended to prevent preterm births works. The panel voted to recommend the FDA withdraw its approval.
Read More